Protection of normal tissues by WR2721 during fractionated irradiation.

[1]  R. Hayes,et al.  Distribution of WR-2721 in normal and malignant tissues of mice and rats bearing solid tumors: dependence on tumor type, drug dose and species. , 1974, Radiation research.

[2]  T. Phillips,et al.  Differential radioprotection of euoxic and hypoxic mouse mammary tumors by a thiophosphate compound. , 1974, Radiology.

[3]  T. Phillips,et al.  Radioprotection of tumor and normal tissues by thiophosphate compounds , 1973, Cancer.

[4]  L. Smith,et al.  Some pharmacologic effects of WR-2721: their role in toxicity and radioprotection. , 1973, Radiation research.

[5]  J. Yuhas.  Radiotherapy of experimental lung tumors in the presence and absence of a radioprotective drug, S-2-(3-aminopropylamino)ethylphosphorothioic acid (WR-2721). , 1973, Journal of the National Cancer Institute.

[6]  G. Fletcher,et al.  Retinal and optic nerve complications in a high dose irradiation technique of ethmoid sinus and nasal cavity. , 1972, Radiology.

[7]  J. Yuhas.  Improvement of lung tumor radiotherapy through differential chemoprotection of normal and tumor tissue. , 1972, Journal of the National Cancer Institute.

[8]  T. Phillips,et al.  Radiobiolgoical and biochemical studies of thiophosphate radioprotective compounds related to cysteamine. , 1971, Radiation research.

[9]  H. Withers,et al.  Microcolony survival assay for cells of mouse intestinal mucosa exposed to radiation. , 1970, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[10]  L. Shukovsky.  Dose, time, volume relationships in squamous cell carcinoma of the supraglottic larynx. , 1970, The American journal of roentgenology, radium therapy, and nuclear medicine.

[11]  J. Yuhas,et al.  Differential chemoprotection of normal and malignant tissues. , 1969, Journal of the National Cancer Institute.

[12]  J. Yuhas,et al.  Chemoprotection against three modes of radiation death in the mouse. , 1969, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[13]  T. Johnston,et al.  S-2-(omega-aminoalkylamino)ethyl dihydrogen phosphorothioates and related compounds as potential antiradiation agents. , 1969, Journal of medicinal chemistry.